Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm.
Nephrotoxic medication-associated acute kidney injury (NTMx-AKI) is a costly clinical phenomenon and more common than previously recognized. Prior efforts to use technology to identify AKI have focused on detection after renal injury has occurred.
Author(s): Kirkendall, E S, Spires, W L, Mottes, T A, Schaffzin, J K, Barclay, C, Goldstein, S L
DOI: 10.4338/ACI-2013-12-RA-0102